INTEGRINS AND HEART DEVELOPMENT
INTEGRINS AND HEART DEVELOPMENT
批准号:
2223858
负责人:
CLAYTON A BUCK
金额:
$26.87万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
1992
资助国家:
美国
项目状态:
已结题
起止时间:
1992-02-01 至 1997-01-31
关键词:
SDS polyacrylamide gel electrophoresis autoradiography cell cell interaction cell migration congenital heart disorder embryo /fetus culture enzyme linked immunosorbent assay heart heart cell histochemistry /cytochemistry histogenesis hybridomas immunoprecipitation in situ hybridization integrins laboratory mouse laboratory rabbit laboratory rat mammalian embryology molecular biology monoclonal antibody northern blottings nucleic acid probes polymerase chain reaction protein structure function receptor expression scintillation counter southern blotting
中文摘要
心脏畸形的发生率为每1000人中有7至10例
出生使先天性心脏病成为最常见的出生形式
叛逃。尽管在诊断和外科方面取得了令人印象深刻的进展
治疗方面,目前尚不清楚其分子基础。
这些畸形。许多无疑是单元格错误的结果
心脏早期发生的迁移或细胞与细胞的相互作用
发展。被称为整合素的细胞表面受体家族
已经被证明能够调节细胞之间的相互作用
与细胞外基质结合。对这些功能的干扰
受体导致细胞在早期的异常行为
形态发生。我们假设整合素是重要的决定因素
心脏早期形态发生的特征。我们进一步假设它们是
在心脏发育期间以编程方式表达,以便不同
整合素在不同的时间和位置表达
在心脏形态发生过程中,该形态发生至少
不仅部分依赖于整合素的表达,而且还依赖于
在正确的时间和地点表达正确的整合素。我们会
用小鼠胚胎来检验这些假设。为了实现这一目标,我们
将首先开发cdna探针、多克隆抗体和克隆。
针对主要整合素α亚基的抗体
在小鼠胚胎中表达。这将通过组装来实现
从小鼠文库中构建完整的小鼠cdna,并在
杆状病毒系统及其纯化蛋白作为免疫原用于
抗体的产生。这种试剂在很大程度上不存在于
小鼠整合素。第二,我们将监测整合素的程序
在小鼠早期发育中的表达1)通过逆转录酶-
内源性整合素基因的聚合酶链式反应扩增。原位杂交
将用于检测放大消息的蜂窝来源;以及
2)用单克隆多克隆抗体进行免疫组织化学
针对小鼠整合素α亚基制备。第三,我们将
确定整合素在肿瘤细胞中表达的功能意义
通过1)早期破坏培养小鼠胚胎的心脏发育
具有生物活性的抗整合素抗体的形态发生;2)
阻断早期心肌或心内膜细胞整合素的合成
使用携带特异性反义结构的逆转录病毒载体
小鼠整合素α亚基;3)干扰正常细胞
通过诱导不适当的整合素表达来相互作用
携带完整整合素α亚单位基因的缺陷型逆转录病毒。
在这项工作完成后,我们将准确地确定
整合素在心脏发育不同阶段的重要性。AS
这些实验将进行组织学评估,我们将知道
整合素在心肌、心内膜、
原始的心管和早期的房室瓣膜。我们将测试
假设有一个精确的整合素表达程序
发展的心脏和决定在什么时候成人的模式
建立了整合素的表达。最后,我们将确定
整合素的表达和程序的功能重要性
整合素在哺乳动物心脏发育过程中的表达。
英文摘要
Malformations of the heart occur at the rate of 7 to 10 cases/1,000 live
births making congenital heart disease the most frequent form of birth
defect. Despite impressive advances in diagnosis and surgical
treatment, there is as yet no understanding of the molecular basis of
these malformations. Many are undoubtedly the result of errors in cell
migration or cell-cell interactions that occur during early heart
development. A family of cell surface receptors known as the integrins
has been shown to mediate cellular interactions with one another and
with the extracellular matrix. Interference with the function of these
receptors results in aberrant behavior of cells during early
morphogenesis. We hypothesize that integrins are important determinants
of early heart morphogenesis. We further postulate that they are
programmatically expressed during heart development such that different
groups of integrins are expressed at different times and locations
during cardiac morphogenesis and that morphogenesis is at least
partially dependent not only on integrin expression, but upon the
expression of the right integrin in the right place and time. We will
test these hypotheses using the mouse embryo. To accomplish this we
will first develop cDNA probes, polyclonal antibodies and monoclonal
antibodies specific for the alpha subunits of the major integrins
expressed in the mouse embryo. This will be accomplished by assembling
complete mouse cDNA constructs from mouse libraries, expressing them in
the baculovirus system and using the purified proteins as immunogens for
antibody production. Such reagents do not, for the most part, exist for
mouse integrins. Second, we will monitor the program of integrin
expression during early mouse development 1) by reverse transcriptase-
PCR amplification of endogenous integrin mRNA. In situ hybridization
will be used to detect the cellular source of the amplified message; and
2) by immunohistochemistry using the monoclonal polyclonal antibodies
prepared against mouse integrin alpha subunits. Third, we will
determine the functional significance of integrin expression in the
developing heart of cultured mouse embryos by 1) disrupting early
morphogenesis with biologically active anti-integrin antibodies; 2)
blocking integrin synthesis in early myocardial or endocardial cells
using retrovirus vectors carrying antisense constructs specific for
mouse integrin alpha subunits; and 3) perturbing normal cellular
interactions by inducing inappropriate integrin expression using
defective retroviruses carrying complete integrin alpha subunit cDNA's.
Upon completion of this work, we will have determined precisely the
importance of integrins to various stages of heart development. As
these experiments will be evaluated histologically, we will know the
role of integrins in the formation of the myocardium, the endocardium,
primitive heart tube and early A-V valves. We will have tested the
hypothesis that there is a precise program of integrin expression in the
developing heart and determined at what point the adult pattern of
integrin expression is established. Finally, we will have determined
the functional importance of both integrin expression and the program of
integrin expression during mammalian heart development.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
S PARRYII A MODEL HIBERNATOR PHYSIOLOGY
-
批准号:7960097
-
项目类别:
-
资助金额:$3.55万
-
财政年份:2009
-
负责人:CLAYTON A BUCK
-
依托单位:
S PARRYII A MODEL HIBERNATOR PHYSIOLOGY
-
批准号:7719972
-
项目类别:
-
资助金额:$3.22万
-
财政年份:2008
-
负责人:CLAYTON A BUCK
-
依托单位:
MOLECULAR/ GENETIC BASIS OF EARLY CONOTRUNCAL MORPHOGENESIS
-
批准号:6565105
-
项目类别:
-
资助金额:$18.67万
-
财政年份:2002
-
负责人:CLAYTON A BUCK
-
依托单位:
MOLECULAR/ GENETIC BASIS OF EARLY CONOTRUNCAL MORPHOGENESIS
-
批准号:6302543
-
项目类别:
-
资助金额:$17.17万
-
财政年份:2000
-
负责人:CLAYTON A BUCK
-
依托单位:
MOLECULAR/ GENETIC BASIS OF EARLY CONOTRUNCAL MORPHOGENESIS
-
批准号:6111039
-
项目类别:
-
资助金额:$17.17万
-
财政年份:1999
-
负责人:CLAYTON A BUCK
-
依托单位:
GENETIC AND MOLECULAR BASIS OF CARDIAC NEURAL CREST IN DEVELOPING CHICK EMBRYO
-
批准号:6110279
-
项目类别:
-
资助金额:$0.0万
-
财政年份:1998
-
负责人:CLAYTON A BUCK
-
依托单位:
MOLECULAR AND GENETIC BASIS OF CONOTRUNCAL MORPHOGENESIS
-
批准号:6110278
-
项目类别:
-
资助金额:$0.0万
-
财政年份:1998
-
负责人:CLAYTON A BUCK
-
依托单位:
GENETIC AND MOLECULAR BASIS OF CARDIAC NEURAL CREST IN DEVELOPING CHICK EMBRYO
-
批准号:6242287
-
项目类别:
-
资助金额:$19.72万
-
财政年份:1997
-
负责人:CLAYTON A BUCK
-
依托单位:
MOLECULAR AND GENETIC BASIS OF CONOTRUNCAL MORPHOGENESIS
-
批准号:6242286
-
项目类别:
-
资助金额:$19.72万
-
财政年份:1997
-
负责人:CLAYTON A BUCK
-
依托单位:
SCOR IN PEDIATRIC CARDIOVASCULAR DISEASE
-
批准号:2228368
-
项目类别:
-
资助金额:$112.62万
-
财政年份:1993
-
负责人:CLAYTON A BUCK
-
依托单位:
SCOR IN PEDIATRIC CARDIOVASCULAR DISEASE
-
批准号:2228365
-
项目类别:
-
资助金额:$116.64万
-
财政年份:1993
-
负责人:CLAYTON A BUCK
-
依托单位:
SCOR IN PEDIATRIC CARDIOVASCULAR DISEASE
-
批准号:2228366
-
项目类别:
-
资助金额:$29.28万
-
财政年份:1993
-
负责人:CLAYTON A BUCK
-
依托单位:
SCOR IN PEDIATRIC CARDIOVASCULAR DISEASE
-
批准号:2029035
-
项目类别:
-
资助金额:$138.07万
-
财政年份:1993
-
负责人:CLAYTON A BUCK
-
依托单位:
SCOR IN PEDIATRIC CARDIOVASCULAR DISEASE
-
批准号:2638016
-
项目类别:
-
资助金额:$143.59万
-
财政年份:1993
-
负责人:CLAYTON A BUCK
-
依托单位:
SCOR IN PEDIATRIC CARDIOVASCULAR DISEASE
-
批准号:2228367
-
项目类别:
-
资助金额:$112.04万
-
财政年份:1993
-
负责人:CLAYTON A BUCK
-
依托单位:
INTEGRINS AND HEART DEVELOPMENT
-
批准号:2223857
-
项目类别:
-
资助金额:$26.49万
-
财政年份:1992
-
负责人:CLAYTON A BUCK
-
依托单位:
ROLE OF INTEGRINS IN MAMMALIAN HEART DEVELOPMENT
-
批准号:3366905
-
项目类别:
-
资助金额:$22.5万
-
财政年份:1992
-
负责人:CLAYTON A BUCK
-
依托单位:
ROLE OF INTEGRINS IN MAMMALIAN HEART DEVELOPMENT
-
批准号:3366906
-
项目类别:
-
资助金额:$22.59万
-
财政年份:1992
-
负责人:CLAYTON A BUCK
-
依托单位:
INTEGRINS AND HEART DEVELOPMENT
-
批准号:2223859
-
项目类别:
-
资助金额:$28.06万
-
财政年份:1992
-
负责人:CLAYTON A BUCK
-
依托单位:
GORDON RESEARCH CONFERENCE: CELL CONTACT AND ADHESION
-
批准号:3435140
-
项目类别:
-
资助金额:$1.45万
-
财政年份:1991
-
负责人:CLAYTON A BUCK
-
依托单位:
海外基金